The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.25617
Abstract: Bronchiolitis obliterans syndrome (BOS) is a life‐threatening respiratory complication of allogeneic hematopoietic stem cell transplantation (HSCT). Although pulmonary function testing is crucial for monitoring BOS, little information exists on the association of these test results… read more here.
Keywords: bronchiolitis obliterans; outcomes children; obliterans syndrome; cell transplantation ... See more keywords
Multivariate modeling using quantitative CT metrics may improve accuracy of diagnosis of bronchiolitis obliterans syndrome after lung transplantation
Sign Up to like & getrecommendations! Published in 2017 at "Computers in biology and medicine"
DOI: 10.1016/j.compbiomed.2017.08.016
Abstract: BACKGROUND To assess how quantitative CT (qCT) metrics compare to pulmonary function testing (PFT) and semi-quantitative image scores (SQS) to diagnose bronchiolitis obliterans syndrome (BOS), manifestation of chronic lung allograft dysfunction after lung transplantation (LTx),… read more here.
Keywords: bronchiolitis obliterans; obliterans syndrome; accuracy; lung transplantation ... See more keywords
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents
Sign Up to like & getrecommendations! Published in 2017 at "Nanotoxicology"
DOI: 10.1080/17435390.2017.1317862
Abstract: Abstract The use of gold nanoparticles (GNPs) as drug delivery system represents a promising issue for diseases without effective pharmacological treatment due to insufficient local drug accumulation and excessive systemic toxicity. Bronchiolitis obliterans syndrome (BOS)… read more here.
Keywords: bronchiolitis obliterans; gold nanoparticles; response; obliterans syndrome ... See more keywords
Effect of azithromycin on bronchiolitis obliterans syndrome in posttransplant recipients: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029160
Abstract: Background: Bronchiolitis obliterans syndrome (BOS) is a devastating complication that occurs after transplantation. Although azithromycin is currently used for the treatment of BOS, the evidence is sparse and controversial. The aim of this meta-analysis is… read more here.
Keywords: meta analysis; effect; obliterans syndrome; term ... See more keywords
Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008095
Abstract: Key Points • Belumosudil is associated with clinical responses in BOS, particularly in less advanced disease.• No significant correlation was identified between FEV1 evaluations and measures of symptoms in predominantly mild or moderate disease. read more here.
Keywords: clinical response; response belumosudil; syndrome combined; belumosudil bronchiolitis ... See more keywords
Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.oa3334
Abstract: Long-term survival after lung transplantation (LTx) is hampered by chronic lung allograft dysfunction, with bronchiolitis obliterans syndrome (BOS) as its most common phenotype. We investigated whether development and timing of bronchiectasis (BRECT) has prognostic significance… read more here.
Keywords: bos; bronchiolitis obliterans; obliterans syndrome; lung transplantation ... See more keywords
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10081887
Abstract: Background: Patients with steroid-refractory intestinal acute graft-versus-host disease (aGvHD) and bronchiolitis obliterans syndrome (BOS) represent a population with a high need for alternative and effective treatment options. Methods: We report real-life data from 18 patients… read more here.
Keywords: intestinal acute; gvhd; obliterans syndrome; bronchiolitis obliterans ... See more keywords